These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 14965273

  • 1. The primary ligand-binding interaction at the GLP-1 receptor is via the putative helix of the peptide agonists.
    Al-Sabah S, Donnelly D.
    Protein Pept Lett; 2004 Feb; 11(1):9-14. PubMed ID: 14965273
    [Abstract] [Full Text] [Related]

  • 2. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
    Al-Sabah S, Donnelly D.
    Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL, Huang Q, Brown TJ, Drucker DJ.
    Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High potency antagonists of the pancreatic glucagon-like peptide-1 receptor.
    Montrose-Rafizadeh C, Yang H, Rodgers BD, Beday A, Pritchette LA, Eng J.
    J Biol Chem; 1997 Aug 22; 272(34):21201-6. PubMed ID: 9261127
    [Abstract] [Full Text] [Related]

  • 10. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
    Coopman K, Wallis R, Robb G, Brown AJ, Wilkinson GF, Timms D, Willars GB.
    Mol Endocrinol; 2011 Oct 22; 25(10):1804-18. PubMed ID: 21868452
    [Abstract] [Full Text] [Related]

  • 11. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
    Mann RJ, Nasr NE, Sinfield JK, Paci E, Donnelly D.
    Br J Pharmacol; 2010 Aug 22; 160(8):1973-84. PubMed ID: 20649595
    [Abstract] [Full Text] [Related]

  • 12. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
    Runge S, Thøgersen H, Madsen K, Lau J, Rudolph R.
    J Biol Chem; 2008 Apr 25; 283(17):11340-7. PubMed ID: 18287102
    [Abstract] [Full Text] [Related]

  • 13. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M, Jehle DR, Fussgaenger RD, Fehmann HC, Jehle PM.
    Am J Physiol Endocrinol Metab; 2000 Jul 25; 279(1):E88-94. PubMed ID: 10893327
    [Abstract] [Full Text] [Related]

  • 14. Medium-dependence of the secondary structure of exendin-4 and glucagon-like-peptide-1.
    Andersen NH, Brodsky Y, Neidigh JW, Prickett KS.
    Bioorg Med Chem; 2002 Jan 25; 10(1):79-85. PubMed ID: 11738609
    [Abstract] [Full Text] [Related]

  • 15. Black widow spider alpha-latrotoxin: a presynaptic neurotoxin that shares structural homology with the glucagon-like peptide-1 family of insulin secretagogic hormones.
    Holz GG, Habener JF.
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Oct 25; 121(2):177-84. PubMed ID: 9972293
    [Abstract] [Full Text] [Related]

  • 16. Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular domain.
    West GM, Willard FS, Sloop KW, Showalter AD, Pascal BD, Griffin PR.
    PLoS One; 2014 Oct 25; 9(9):e105683. PubMed ID: 25180755
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity studies of glucagon-like peptide-1.
    Adelhorst K, Hedegaard BB, Knudsen LB, Kirk O.
    J Biol Chem; 1994 Mar 04; 269(9):6275-8. PubMed ID: 8119974
    [Abstract] [Full Text] [Related]

  • 18. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
    Heller RS, Kieffer TJ, Habener JF.
    Biochem Biophys Res Commun; 1996 Jun 25; 223(3):624-32. PubMed ID: 8687446
    [Abstract] [Full Text] [Related]

  • 19. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.
    Luque MA, González N, Márquez L, Acitores A, Redondo A, Morales M, Valverde I, Villanueva-Peñacarrillo ML.
    J Endocrinol; 2002 Jun 25; 173(3):465-73. PubMed ID: 12065236
    [Abstract] [Full Text] [Related]

  • 20. A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells.
    Perry T, Lahiri DK, Chen D, Zhou J, Shaw KT, Egan JM, Greig NH.
    J Pharmacol Exp Ther; 2002 Mar 25; 300(3):958-66. PubMed ID: 11861804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.